1)Jordan A, Baum J:Basic tear flow;does it exist? Ophthalmology 87:920-930, 1980
keratomileusis. Am J Ophthalmol 132:1-7, 2001
3)Chikama T, Fukuda K, Morishige N et al:Treatment of neurotrophic keratopathy with substance-P-derived peptide(FGLM)and insulin-like growth factor I. Lancet 351:1783-1784, 1998
confocal microscopy study. Ophthalmology 117:1930-1936, 2010
5)Rosenberg ME, Tervo TM, Immonen IJ et al:Corneal structure and sensitivity in type 1 diabetes mellitus. Invest Ophthalmol Vis Sci 41:2915-2921, 2000
6)Rao GN, John T, Ishida N et al:Recovery of corneal sensitivity in grafts following penetrating keratoplasty. Ophthalmology 92:1408-1411, 1985
7)Nishida T, Chikama T, Morishige N et al:Persistent epithelial defects due to neurotrophic keratopathy treated with a substance p-derived peptide and insulin-like growth factor 1. Jpn J Ophthalmol 51:442-447, 2007
8)Patel SV, Erie JC, McLaren JW et al:Keratocyte and subbasal nerve density after penetrating keratoplasty. Trans Am Ophthalmol Soc 105:180-189;discussion 189-190, 2007
9)Pasterkamp RJ, Anderson PN, Verhaagen J:Peripheral nerve injury fails to induce growth of lesioned ascending dorsal column axons into spinal cord scar tissue expressing the axon repellent Semaphorin3A. Eur J Neurosci 13:457-471, 2001
10)Kaneko S, Iwanami A, Nakamura M et al:A selective Sema3A inhibitor enhances regenerative responses and functional recovery of the injured spinal cord. Nat Med 12:1380-1389, 2006
11)Omoto M, Yoshida S, Shimmura S et al:The semaphorin 3A Inhibitor SM-345431 Accelerates Peripheral Nerve Regeneration and Sensitivity in a Murine Corneal Transplantation Model. PLoS One 2012(in press)